FDA Adverse Event Malfunction Summary report: N

SYSMEX PS-10

MDR report key: 21130098 · Received January 10, 2025

Report

Report Number
1000515253-2025-00002
Event Type
Malfunction
Date Received
January 10, 2025
Date of Event
December 12, 2024
Report Date
July 22, 2025
Manufacturer
SYSMEX CORPORATION
Product Code
PER
UDI-DI
04987562501908
PMA / PMN Number
EXEMPT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE USER OF AUTOMATED PIPETTING SYSTEM PS-10, SERIAL NUMBER (B)(6) REPORTED ON 12/6/2024 PRESENCE OF EXTRA PARTICLE POPULATIONS IN FLOW CYTOMETRY RESULTS. NO ERRONEOUS RESULTS WERE REPORTED. THERE WAS NO REPORT OF SERIOUS INJURY OR DEATH DUE TO THE EVENT. ON 12/12/2024 IT WAS CONFIRMED THAT A SOFTWARE DEFECT HAD BEEN INTRODUCED WITH PS-10 SOFTWARE VERSION 1.5 AND ALSO MANIFESTED IN SOFTWARE VERSION 1.6. VERSIONING DOWN TO SOFTWARE VERSION 1.4 RESOLVES THE ISSUE. ON 1/9/2025 A TECHNICAL PRODUCT MANAGER CONFIRMED THE SOFTWARE DEFECT CAUSED THE EVENT REPORTED FOR PS-10 SN (B)(6). THE PS-10 IS AN OPEN SYSTEM WHERE A VARIETY OF ANTIBODY REAGENT VIALS MAY BE USED FOR SAMPLE PREPARATION. OMISSION OF THE PROBE WASH STEP AND POTENTIAL ANTIBODY CARRY-OVER MAY LEAD TO POSSIBLE ERRONEOUS REPRESENTATION OF ANTIGEN MARKERS IN A SAMPLE AND THUS GENERATE ERRONEOUS RESULTS IN SUBSEQUENT FLOW CYTOMETRY ANALYSIS. IF THE INCORRECT RESULT IS OVERLOOKED AND REPORTED, IT MAY LEAD TO MISDIAGNOSIS AND INCORRECT TREATMENT. THE RISK TO HEALTH IS DETERMINED BY THE USER'S APPLICATION IN FLOW CYTOMETRY ANALYSIS, THE INTENDED PURPOSE OF THE CLINICAL TEST. NO WARNING IS ISSUED BY THE DEVICE TO ALERT THE OPERATOR OF THE MISSED WASH SEQUENCE. NO MISDIAGNOSIS AND/OR INCORRECT TREATMENT HAVE BEEN REPORTED. SYSMEX AMERICA INCORPORATED, SAI, BECAME AWARE OF THE PRODUCT PROBLEM ON 12/17/2024. ON 12/23/2024, SYSMEX CORPORATION JAPAN (S-CORP), THE LEGAL MANUFACTURER OF THE PS-10, INITIATED A FIELD CORRECTIVE ACTION (FCA) 2422. ON 1/6/2025, SAI RELEASED PRODUCT NOTIFICATION (PN) CF-07577 TO CUSTOMERS AND INITIATED SAI FIELD CORRECTIVE ACTION (FCA) 2024-004-C. THIS EVENT IS DEEMED REPORTABLE TO THE FDA DUE TO A PRODUCT PROBLEM, PS-10 SOFTWARE VERSION 1.5 AND SOFTWARE VERSION 1.6 SOFTWARE DEFECT, CAUSING MISSED WASH SEQUENCES AFFECTING SUBSEQUENT FLOWCYTOMETRY RESULT ACCURACY, WHERE AN FCA IS BEING PERFORMED TO PREVENT THE RISK OF HARM TO PATIENTS.

Description of Event or Problem · 0

A SOFTWARE DEFECT WAS IDENTIFIED IN SAMPLE PREPARATION SYSTEM PS-10 SOFTWARE VERSION 1.5 AND SOFTWARE VERSION 1.6, WHERE OMISSION OF THE PROBE WASH STEP AND POTENTIAL ANTIBODY CARRY-OVER MAY LEAD TO POSSIBLE ERRONEOUS REPRESENTATION OF ANTIGEN MARKERS IN A SAMPLE AND THUS GENERATE ERRONEOUS RESULTS IN SUBSEQUENT FLOW CYTOMETRY ANALYSIS. THERE HAS BEEN NO REPORT OF INCORRECT TREATMENT, SERIOUS INJURY OR DEATH DUE TO THE PRODUCT PROBLEM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
516917 SYSMEX PS-10 PS-10 SAMPLE PREPARATION SYSTEM PER SYSMEX CORPORATION PS-10 04987562501908

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown